AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
New Repatha® (evolocumab) Data Show No Decline in Cognitive Function Associated With Very Low Levels of LDL-C Olpasiran Research Provides Further ...
United States Puerto Rico Prnewswire Amgen Jessica Akopyan Arterioscler Thromb Vasc Robert Giugliano
Source: businessinsider.com